OCUL (STOCKS)
Ocular Therapeutix, Inc.
$9.100000
+0.160000 (+1.79%)
Prev close: $8.940000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Pravin U. Dugel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,969.55M
- Employees
- 274
- P/E (TTM)
- -6.18
- P/B (TTM)
- 3.38
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.40 | $-0.32 | -0.0815 | -25.59% |
|
Dec 2025 (Q4)
|
$-0.29 | $-0.33 | +0.0423 | +12.73% |
|
Sep 2025 (Q3)
|
$-0.38 | $-0.37 | -0.0060 | -1.60% |
|
Jun 2025 (Q2)
|
$-0.39 | $-0.36 | -0.0283 | -7.82% |
Financial Statements
| Revenues | $52.04M |
| Benefits Costs and Expenses | $341.64M |
| Cost Of Revenue | $6.64M |
| Costs And Expenses | $351.48M |
| Gross Profit | $45.40M |
| Nonoperating Income/Loss | $8.94M |
| Operating Expenses | $344.84M |
| Research and Development | $220.45M |
| Other Operating Expenses | $124.38M |
| Operating Income/Loss | -$299.44M |
| Income/Loss From Continuing Operations After Tax | -$290.50M |
| Income/Loss From Continuing Operations Before Tax | -$289.78M |
| Net Income/Loss | -$290.50M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$290.50M |
| Net Income/Loss Available To Common Stockholders, Basic | -$290.50M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.44 |
| Diluted Earnings Per Share | -$1.44 |
| Basic Average Shares | 592,498,634 |
| Diluted Average Shares | 592,498,634 |
| Assets | $732.53M |
| Current Assets | $706.00M |
| Inventory | $3.74M |
| Other Current Assets | $702.26M |
| Noncurrent Assets | $26.53M |
| Fixed Assets | $18.43M |
| Other Non-current Assets | $8.11M |
| Liabilities | $150.96M |
| Current Liabilities | $47.68M |
| Accounts Payable | $8.03M |
| Wages | $8.03M |
| Other Current Liabilities | $31.62M |
| Noncurrent Liabilities | $103.27M |
| Equity | $581.57M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $581.57M |
| Liabilities And Equity | $732.53M |
| Net Cash Flow From Operating Activities | -$226.21M |
| Net Cash Flow From Operating Activities, Continuing | -$226.21M |
| Net Cash Flow From Investing Activities | -$14.61M |
| Net Cash Flow From Investing Activities, Continuing | -$14.61M |
| Net Cash Flow From Financing Activities | $557.83M |
| Net Cash Flow From Financing Activities, Continuing | $557.83M |
| Net Cash Flow | $317.02M |
| Net Cash Flow, Continuing | $317.02M |
| Comprehensive Income/Loss | -$290.50M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$290.50M |
| Other Comprehensive Income/Loss | $0.00 |